Table 3.
Patient no. | IHC | IL-6 level (pg/mL) by ELISA | |||||
---|---|---|---|---|---|---|---|
(N = 7) | p27 | Ki-67 | RB | p-RB | Pre-treatment | Pre-second treatment | At disease progression |
UCD-001 | 30% | 30% | 30% | 0 | 1.8 | – | 12.5 |
UCD-002 | 0 | 50% | 60% | 0 | 110.5 | 328.7 | 213.2 |
UCD-003 | 90% | 60% | – | – | 0 | 0.3 | 10.9 |
UCD-004 | 80% | 35% | 0 | 0 | 6.3 | 7.8 | 16.7 |
UCD-005 | 90% | 40% | – | – | – | – | – |
UCD-006 | 100% | 90% | – | – | 2.6 | 5.0 | 6.0 |
UCD-007 | 0 | 10% | 0 | 0 | 3.7 | 13.5 | 7.8 |
IHC immunohistochemistry stain. ELISA Enzyme-Linked Immunosorbent Assay
The reported normal value for IL-6 was 4.3 pg/mL